XELEVIA

Details for Australian Trade Mark No. 1260141 (hide)

Owner Merck Sharp & Dohme Corp. a New Jersey corporation

Service Shelston IP

Filing Date 1 September 2008

Classes

Class 5 Pharmaceutical preparations for the treatment of urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculo-skeletal disorders, osteoporosis, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations, antiemetic preparations and vaccine preparations

Event Publications

25 September 2008 Application filed

15 January 2009 Application Accepted

4 June 2009 Trade Mark Registered/Protected

28 January 2010 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

26 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp. a New Jersey corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1260142-VELMETIA

1260140-XEN